Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/29/2019
Aurobindo’s generic Lodosyn gets FDA OK
Carbidopa tablets had a market value of roughly $7.7 million for the 12 months ending August 2019, according to IQVIA. - 10/29/2019
Biogen, Alkermes get FDA OK for Vumerity
Biogen's and Alkermes' Vumerity is a new oral treatment option for relapsing forms of multiple sclerosis. - 10/29/2019
NCPA names new president, approves changes on pharmacy payment model
NCPA delegates adopted several resolutions, including one urging policymakers to support reforms compensating pharmacists for the true cost of dispensing medicines. - 10/28/2019
Hy-Vee, Hormel Foods donate Skippy peanut butter to Midwestern food banks
A hefty peanut butter donation from Hy-Vee and Hormel Foods equates to more than 184,467 peanut butter sandwiches. - 10/28/2019
NCPA releases annual digest, launches CBD Source for pharmacists with PRS
NCPA's new CBD Source for community pharmacists will be sending product samples to an independent lab to verify strength and product integrity. - 10/28/2019
Lupin gets FDA nod for generic Depakote
Divalproex sodium ER tablets, 250 mg and 500 mg had a market value of roughly $159 million, according to IQVIA June 2019 data. - 10/28/2019
University of Oklahoma College of Pharmacy wins 2019 Pruitt-Schutte student business plan competition
The 2019 Pruitt-Schutte student business plan competition drew participants from 36 schools and colleges of pharmacy across the United States. - 10/28/2019
Steve Moore receives NCPA’s Independent Pharmacist of the Year Award
The NCPA independent pharmacist of the year award is sponsored by Upsher-Smith for the 11th consecutive year - 10/27/2019
Alembic’s Aleor joint venture gets FDA green light for generic desonide
Desonide ointment, 0.05%, had a market value of $13 million for the 12 months ended December 2018, according to IQVIA. - 10/27/2019
Sun Pharmaceuticals introduces pantoprazole injection
Sun Pharmaceuticals' pantoprazole injection is intended to support a product shortage.
